New Age Alpha Advisors LLC acquired a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 45,741 shares of the real estate investment trust’s stock, valued at approximately $866,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in SBRA. Principal Financial Group Inc. increased its stake in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after buying an additional 4,431,897 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Sabra Healthcare REIT by 1,019.8% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after buying an additional 2,736,993 shares in the last quarter. Balyasny Asset Management L.P. acquired a new stake in shares of Sabra Healthcare REIT in the second quarter valued at $49,955,000. Qube Research & Technologies Ltd increased its stake in shares of Sabra Healthcare REIT by 856.5% in the second quarter. Qube Research & Technologies Ltd now owns 1,398,965 shares of the real estate investment trust’s stock valued at $25,797,000 after buying an additional 1,252,708 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Sabra Healthcare REIT by 33.7% in the third quarter. JPMorgan Chase & Co. now owns 3,589,253 shares of the real estate investment trust’s stock valued at $66,904,000 after buying an additional 903,841 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on SBRA. Citigroup raised their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, February 18th. Scotiabank raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Truist Financial raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, March 13th. UBS Group raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Finally, Cantor Fitzgerald raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.30.
Sabra Healthcare REIT Price Performance
Sabra Healthcare REIT stock opened at $20.45 on Thursday. The business’s 50-day simple moving average is $20.32 and its 200 day simple moving average is $19.69. The stock has a market cap of $5.16 billion, a price-to-earnings ratio of 32.46, a P/E/G ratio of 1.56 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a 12-month low of $17.13 and a 12-month high of $21.28. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. The business had revenue of $221.75 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.
Sabra Healthcare REIT Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Friday, May 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.
Sabra Healthcare REIT Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Read More
- Five stocks we like better than Sabra Healthcare REIT
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
